导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.92% | 726/1050 |
| 近一周 | -1.98% | 397/1104 |
| 近一月 | -6.20% | 745/1102 |
| 近一季 | -19.77% | 973/1092 |
| 近半年 | -2.45% | 488/1070 |
| 近一年 | -8.86% | 724/1018 |
| 近两年 | 44.06% | 546/926 |
| 近三年 | 17.15% | 525/834 |
| 成立以来 | -37.46% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.40% 881/1070 |
43.00% 254/1101 |
- - |
- - |
| 2025 | 47.32% 224/1065 |
3.77% 496/1014 |
3.66% 380/1038 |
44.56% 132/1050 |
-5.26% 712/1065 |
| 2024 | -12.85% 818/1011 |
-7.31% 663/960 |
-10.02% 868/983 |
18.13% 101/991 |
-11.55% 941/1011 |
| 2023 | -30.86% 817/952 |
-9.38% 848/880 |
-8.34% 706/895 |
-11.92% 676/915 |
-5.50% 560/952 |
| 2022 | -24.76% 486/867 |
-15.94% 307/773 |
5.35% 501/806 |
-19.11% 736/845 |
5.03% 205/867 |
| 2021 | -26.94% 541/740 |
-11.46% 515/580 |
12.88% 289/659 |
-13.46% 584/704 |
-15.53% 685/740 |
| 2020 | 43.09% 280/554 |
5.19% 73/419 |
26.45% 175/466 |
-3.39% 452/517 |
11.35% 317/554 |
| 2019 | 23.94% 319/410 |
26.29% 611/1146 |
-11.15% 1120/1228 |
7.45% 153/390 |
2.80% 376/410 |
| 2018 | -25.32% 153/349 |
- - |
-10.72% 526/990 |
-7.01% 575/1000 |
-2.68% 32/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 东吴双三角股票C VS. 东吴新产业精选股票A(580008) |